# FDA Inspection 1025392 - Blood Bank of Delmarva, A Division of New York Blood Center, Inc. - August 28, 2017

Source: https://www.keypedia.com/records/fda_inspections/blood-bank-of-delmarva-a-division-of-new-york-blood-center-inc/f3ca3bdd-e4ec-49ba-8746-70b693152e33
Source feed: FDA_Inspections

> FDA Inspection 1025392 for Blood Bank of Delmarva, A Division of New York Blood Center, Inc. on August 28, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1025392
- Company Name: Blood Bank of Delmarva, A Division of New York Blood Center, Inc.
- Inspection Date: 2017-08-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1109451 - 2019-11-12](https://www.keypedia.com/records/fda_inspections/blood-bank-of-delmarva-a-division-of-new-york-blood-center-inc/4eeaf187-991a-4009-98f9-cce515288d0b)
- [FDA Inspection 932165 - 2015-06-15](https://www.keypedia.com/records/fda_inspections/blood-bank-of-delmarva-a-division-of-new-york-blood-center-inc/36a027da-1221-41d1-a875-21c318017b1e)

Company: https://www.keypedia.com/companies/blood-bank-of-delmarva-a-division-of-new-york-blood-center-inc/b37b0021-f26c-40ed-882d-8400e3d2a1dc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d